Mallinckrodt Plc (MNK)

Trade MNK now with
3/19/2018 7:49:31 AM Mallinckrodt Closes Sale Of RECOTHROM And PREVELEAK To Baxter
2/27/2018 6:07:38 AM Mallinckrodt Q4 GAAP EPS From Cont Ops $17.40 Vs Loss $1.67 Last Year
2/23/2018 6:56:51 AM Mallinckrodt Receives FDA Acceptance Of Stannsoporf In New Drug Application Filing
2/14/2018 6:31:46 AM Mallinckrodt Enrolls First Patient In Phase 1 Study Of ExpressGraft C9T1 Skin Tissue
2/13/2018 9:03:06 AM Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals
2/6/2018 5:54:23 PM Boyd Gaming Set To Join S&P MidCap 400; Ring Energy, James River Group And EVERTEC To Join S&P SmallCap 600
2/1/2018 9:06:35 AM Mallinckrodt Appoints Mark Casey As General Counsel
1/8/2018 7:46:29 AM Baxter Announces Agreement To Acquire Two Hemostat And Sealant Products From Mallinckrodt
12/26/2017 6:46:43 AM Mallinckrodt To Acquire Sucampo Pharma For About $1.2 Bln
12/11/2017 9:18:20 AM Mallinckrodt Closes Acquisition Of Ocera Therapeutics
12/4/2017 9:58:20 AM Mallinckrodt Presents Health Economic Data On Management Of Infantile Spasms At American Epilepsy Society Annual Meeting
11/8/2017 11:27:36 AM Canaccord Is Lowering Mallinckrodt plc (MNK) FY18 Rev. Estimate To 3.22 Billion From 3.35 Billion